Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked. This reflects a site access issue rather than a substantive update to the study content.SummaryDifference17%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA funding note for NIH grant/contract was added to the record, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision on the page updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a new page revision has been published. This reflects a minor internal update to the page metadata rather than changes to the study's content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page's revision label changed from v3.6.2 to v3.6.3. This indicates a minor update to the page or its assets rather than a change to core content and user-facing features.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build update. This update does not modify the study details or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.